MG-101 (ALLN) is an inhibitor of cysteine proteases, specifically inhibiting calpain I, calpain II, cathepsin B, and cathepsin L with Kis of 190, 220, 150, and 500 pM, respectively. It induces apoptosis and inhibits tumor growth, making it suitable for research on colon cancer. For research use only.
- Inhibits cysteine proteases: calpain I, calpain II, cathepsin B, and cathepsin L
- Induces apoptosis
- Inhibits tumor growth
- Can be used for colon cancer research